1. Home
  2. KZIA vs BNZI Comparison

KZIA vs BNZI Comparison

Compare KZIA & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • BNZI
  • Stock Information
  • Founded
  • KZIA 1994
  • BNZI 2016
  • Country
  • KZIA Australia
  • BNZI United States
  • Employees
  • KZIA N/A
  • BNZI N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • BNZI
  • Sector
  • KZIA Health Care
  • BNZI
  • Exchange
  • KZIA Nasdaq
  • BNZI Nasdaq
  • Market Cap
  • KZIA 6.0M
  • BNZI 8.9M
  • IPO Year
  • KZIA 1999
  • BNZI N/A
  • Fundamental
  • Price
  • KZIA $0.89
  • BNZI $1.46
  • Analyst Decision
  • KZIA Strong Buy
  • BNZI Strong Buy
  • Analyst Count
  • KZIA 2
  • BNZI 1
  • Target Price
  • KZIA $11.50
  • BNZI $125.00
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • BNZI 4.7M
  • Earning Date
  • KZIA 03-26-2025
  • BNZI 03-04-2025
  • Dividend Yield
  • KZIA N/A
  • BNZI N/A
  • EPS Growth
  • KZIA N/A
  • BNZI N/A
  • EPS
  • KZIA N/A
  • BNZI N/A
  • Revenue
  • KZIA $1,655,324.00
  • BNZI $4,310,782.00
  • Revenue This Year
  • KZIA N/A
  • BNZI $5.58
  • Revenue Next Year
  • KZIA N/A
  • BNZI $58.87
  • P/E Ratio
  • KZIA N/A
  • BNZI N/A
  • Revenue Growth
  • KZIA 248000.00
  • BNZI N/A
  • 52 Week Low
  • KZIA $0.85
  • BNZI $1.21
  • 52 Week High
  • KZIA $15.80
  • BNZI $51.50
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 29.20
  • BNZI 44.86
  • Support Level
  • KZIA $0.90
  • BNZI $1.51
  • Resistance Level
  • KZIA $1.60
  • BNZI $1.71
  • Average True Range (ATR)
  • KZIA 0.21
  • BNZI 0.23
  • MACD
  • KZIA 0.01
  • BNZI -0.02
  • Stochastic Oscillator
  • KZIA 2.23
  • BNZI 0.80

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.

Share on Social Networks: